NEW YORK (GenomeWeb News) – Genetic test maker Interleukin Genetics reported after the close of the market Thursday that its second-quarter revenues fell 57 percent year over year due to lower contract research revenue.
The Waltham, Mass.-based firm generated total revenues of $222,993 for the three-month period ended June 30, down from total revenues of $521,619 for the second quarter of 2008. The company's contract service revenues fell sharply to $119,046 from $402,280, while its genetic testing service revenue increased to $95,309 from $90, 993.